The Future of Co-Folding and Federated Learning with Apheris

AI is transforming drug discovery — but collaboration and data privacy remain major roadblocks.

In this episode of Data in Biotech, Robin Roehm, CEO and Co-Founder of Apheris, joins Ross Katz to explore how federated learning is revolutionizing the way pharma companies train AI models — enabling secure, cross-company collaboration without moving sensitive data.

What you’ll learn:

>> Why federated learning is a game-changer for pharma and biotech
>> How OpenFold 3 builds on AlphaFold’s legacy to solve the protein-ligand interaction challenge
>> How Apheris enables collaboration between major pharma players while preserving privacy
>> Why high-quality, proprietary datasets are key to advancing co-folding models

Listen to the full discussion on Data in Biotech:

Apple: https://lnkd.in/eTNUz8Wk
‍Spotify: https://lnkd.in/erKsrxH3
‍YouTube: https://lnkd.in/edN__jmc

#DataInBiotech #Apheris #AI #Biotech #FederatedLearning #DrugDiscovery #LifeSciences

‍